Abstract
The development of nanotechnology has completely changed doctor’s perceptions of current cancer treatments. Nanotherapeutics may replace conventional cancer treatment methods like radiotherapy, chemotherapy, and surgery. In this review, we have reviewed the recently-developed multifunctional nanoparticles, i.e., metal nanoparticles, magnetic nanoparticles, carbon-based nanoparticles, and nanocomposites, as well as their uses in the field of cancer research, including diagnostics (including positron emission tomography, computed tomography, magnetic resonance imaging), targeted drug delivery, overcoming multidrug resistance, and therapy (i.e., photothermal therapy, photodynamic therapy, sonodynamic therapy, hyperthermal therapy) efficiently. The drug encapsulation and functional surface modifications of nanoparticles have helped in the reduction of various limitations associated with conventional methods that include site-specific anticancer drug delivery and real-time cancer cell monitoring. The multifunctional antitumor systems based on nanomaterials exhibit tumor cell imaging, reactive oxygen species production with high cytotoxicity, and enhanced tumor inhibition rates. Various mechanisms of cancer cell death such as apoptotic and non-apoptotic (cuproptosis, pyroptosis, and ferroptosis) have also been discussed. Additionally, we have outlined the difficulties, future prospects, benefits, drawbacks, and some clinical data related to nanoparticles utilized in cancer theranostics. In this review, we will classify the fundamental nanomaterials and highlight the development in the field of cancer.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs42247-023-00539-3/MediaObjects/42247_2023_539_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs42247-023-00539-3/MediaObjects/42247_2023_539_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs42247-023-00539-3/MediaObjects/42247_2023_539_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs42247-023-00539-3/MediaObjects/42247_2023_539_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs42247-023-00539-3/MediaObjects/42247_2023_539_Fig4_HTML.png)
Similar content being viewed by others
References
S. Maurya, S. Tiwari, M.C. Mothukuri, C.M. Tangeda, R.N.S. Nandigam, D.C. Addagiri, A review on recent developments in cancer detection using machine learning and deep learning models. Biomed. Signal Process. Control. 80, 104398 (2023). https://doi.org/10.1016/j.bspc.2022.104398
P. Bisoyi, A brief tour guide to cancer disease. Underst. Cancer From Basics to Ther., 1–20 (2022). https://doi.org/10.1016/B978-0-323-99883-3.00006-8
A. Mahmood, R. Srivastava, Etiology of cancer. Underst. Cancer From Basics to Ther., 37–62 (2022). https://doi.org/10.1016/B978-0-323-99883-3.00008-1
S.B. Prasad, Cancer and apoptosis. Underst. Cancer From Basics to Ther., 103–116 (2022). https://doi.org/10.1016/B978-0-323-99883-3.00015-9
S. Prabhu, K. Prasad, A. Robels-Kelly, X. Lu, AI-based carcinoma detection and classification using histopathological images: a systematic review. Comput. Biol. Med. 142, 105209 (2022). https://doi.org/10.1016/J.COMPBIOMED.2022.105209
A. Pulumati, A. Pulumati, B.S. Dwarakanath, A. Verma, R.V.L. Papineni, Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep. 6 (2023). https://doi.org/10.1002/CNR2.1764
W. Yin, F. Pan, J. Zhu, J. Xu, D. Gonzalez-Rivas, M. Okumura, Z. Tang, Y. Yang, Nanotechnology and nanomedicine: a promising avenue for lung cancer diagnosis and therapy. Engineering. 7, 1577–1585 (2021). https://doi.org/10.1016/J.ENG.2020.04.017
I. Khan, K. Saeed, I. Khan, Nanoparticles: properties, applications and toxicities. Arab. J. Chem. 12, 908–931 (2019). https://doi.org/10.1016/J.ARABJC.2017.05.011
R.R. Miranda, I. Sampaio, V. Zucolotto, Exploring silver nanoparticles for cancer therapy and diagnosis. Colloids Surfaces B Biointerfaces. 210, 112254 (2022). https://doi.org/10.1016/J.COLSURFB.2021.112254
Z. Cheng, X. Yan, X. Sun, B. Shen, S.S. Gambhir, Tumor molecular imaging with nanoparticles. Engineering. 2, 132–140 (2016). https://doi.org/10.1016/J.ENG.2016.01.027
M. Hegde, N. Naliyadhara, J. Unnikrishnan, M.S. Alqahtani, M. Abbas, S. Girisa, G. Sethi, A.B. Kunnumakkara, Nanoparticles in the diagnosis and treatment of cancer metastases: current and future perspectives. Cancer Lett. 556, 216066 (2023). https://doi.org/10.1016/J.CANLET.2023.216066
N.H. Nam, N.H. Luong, Nanoparticles: synthesis and applications. Mater. Biomed. Eng. Inorg. Micro- Nanostructures., 211–240 (2019). https://doi.org/10.1016/B978-0-08-102814-8.00008-1
Y. Zhu, Y. Liu, K. Khan, G. Arkin, A.K. Tareen, Z. **e, T. He, L. Su, F. Guo, X.S. Lai, J. Xu, J. Zhang, Ultrasound combined with nanomaterials for cancer therapy. Mater. Today Adv. 17, 100330 (2023). https://doi.org/10.1016/J.MTADV.2022.100330
E.R. Evans, P. Bugga, V. Asthana, R. Drezek, Metallic nanoparticles for cancer immunotherapy. Mater. Today. 21, 673–685 (2018). https://doi.org/10.1016/J.MATTOD.2017.11.022
R. Sharma, U. Agrawal, N. Mody, S. Dubey, S.P. Vyas, Engineered nanoparticles as a precise delivery system in cancer therapeutics. Eng. Nanobiomaterials Appl. Nanobiomaterials., 397–427 (2016). https://doi.org/10.1016/B978-0-323-41532-3.00013-0
R. Krishna, L.D. Mayer, Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11, 265–283 (2000). https://doi.org/10.1016/S0928-0987(00)00114-7
I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 64, 24–36 (2012). https://doi.org/10.1016/J.ADDR.2012.09.006
L.R. Singha, N. Ahmed, M.K. Das, Theranostic nanoparticles engineered for clinic and pharmaceutics, Multifunct. Theranostic Nanomedicines. Cancer., 345–365 (2021). https://doi.org/10.1016/B978-0-12-821712-2.00010-4
S. Indoria, V. Singh, M.F. Hsieh, Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review. Int. J. Pharm. 582, 119314 (2020). https://doi.org/10.1016/J.IJPHARM.2020.119314
C. Zavaleta, D. Ho, E.J. Chung, Theranostic nanoparticles for tracking and monitoring disease state. SLAS Technol. 23, 281–293 (2018). https://doi.org/10.1177/2472630317738699
C. Enrico, Nanotheranostics and theranostic nanomedicine for diseases and cancer treatment. Des. Nanostructures Theranostics Appl., 41–68 (2018). https://doi.org/10.1016/B978-0-12-813669-0.00002-6
S. Sim, N.K. Wong, Nanotechnology and its use in imaging and drug delivery (Review). Biomed. Reports. 14, 1–9 (2021). https://doi.org/10.3892/BR.2021.1418/HTML
Z. Cheng, M. Li, R. Dey, Y. Chen, Nanomaterials for cancer therapy: current progress and perspectives. J. Hematol. Oncol 14(2021), 1–27 (2021). https://doi.org/10.1186/S13045-021-01096-0
C.M. Hartshorn, M.S. Bradbury, G.M. Lanza, A.E. Nel, J. Rao, A.Z. Wang, U.B. Wiesner, L. Yang, P. Grodzinski, Nanotechnology strategies to advance outcomes in clinical cancer care. ACS Nano. 12, 24–43 (2018). https://doi.org/10.1021/ACSNANO.7B05108/ASSET/IMAGES/MEDIUM/NN-2017-051084_0009.GIF
Clinical study on the harvesting lymph nodes with carbon nanoparticles for advanced gastric cancer - full text view - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT02123407?term=phase+3++nanoparticle&cond=cancer&draw=2&rank=5 (accessed June 10, 2023)
Carbon nanoparticles vs indocyanine green - full text view - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/NCT04759820?term=phase+3+carbon+nanoparticle&cond=cancer&draw=2&rank=3 (accessed June 10, 2023)
Pre-operative nodal staging of thyroid cancer using USPIO MRI: preliminary study - full text view - ClinicalTrials.gov, (n.d.). https://clinicaltrials.gov/ct2/show/study/NCT01927887?term=iron+oxide+nanoparticle&cond=Cancer&draw=2&rank=8 (accessed June 9, 2023).
R. Zhang, F. Kiessling, T. Lammers, R.M. Pallares, Clinical translation of gold nanoparticles, Drug Deliv. Transl. Res. 13, 378–385 (2023). https://doi.org/10.1007/S13346-022-01232-4/FIGURES/2
P. Singh, S. Pandit, V.R.S.S. Mokkapati, A. Garg, V. Ravikumar, I. Mijakovic, Gold nanoparticles in diagnostics and therapeutics for human cancer. Int. J. Mol. Sci. 19 (2018). https://doi.org/10.3390/IJMS19071979
F. Peng, M. Liao, R. Qin, S. Zhu, C. Peng, L. Fu, Y. Chen, B. Han, Regulated cell death (RCD) in cancer: key pathways and targeted therapies, Signal Transduct. Target. Ther 7(2022), 1–66 (2022). https://doi.org/10.1038/s41392-022-01110-y
D. De Stefano, R. Carnuccio, M.C. Maiuri, Nanomaterials toxicity and cell death modalities. J. Drug Deliv. 2012, 1–14 (2012). https://doi.org/10.1155/2012/167896
D.D. Ma, W.X. Yang, Engineered nanoparticles induce cell apoptosis: potential for cancer therapy. Oncotarget. 7, 40882 (2016). https://doi.org/10.18632/ONCOTARGET.8553
J. Bao, Z. Jiang, W. Ding, Y. Cao, L. Yang, J. Liu, Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells. Nanotechnol. Rev. 11, 1911–1926 (2022). https://doi.org/10.1515/NTREV-2022-0114/ASSET/GRAPHIC/J_NTREV-2022-0114_FIG_007.JPG
A.K. Wani, N. Akhtar, T.u.G. Mir, R. Singh, P.K. Jha, S.K. Mallik, S. Sinha, S.K. Tripathi, A. Jain, A. Jha, H.P. Devkota, A. Prakash, Targeting apoptotic pathway of cancer cells with phytochemicals and plant-based nanomaterials. Biomolecules. 13 (2023). https://doi.org/10.3390/BIOM13020194
C.M. Pfeffer, A.T.K. Singh, Apoptosis: a target for anticancer therapy. Int. J. Mol. Sci. 19 (2018). https://doi.org/10.3390/IJMS19020448
Y. Yang, X. Du, Q. Wang, J. Liu, E. Zhang, L. Sai, C. Peng, M.F. Lavin, A.J. Yeo, X. Yang, H. Shao, Z. Du, Mechanism of cell death induced by silica nanoparticles in hepatocyte cells is by apoptosis. Int. J. Mol. Med. 44, 903–912 (2019). https://doi.org/10.3892/IJMM.2019.4265/HTML
S.W. Wang, C.H. Lee, M.S. Lin, C.W. Chi, Y.J. Chen, G.S. Wang, K.W. Liao, L.P. Chiu, S.H. Wu, D.M. Huang, L. Chen, Y.S. Shen, ZnO nanoparticles induced caspase-dependent apoptosis in gingival squamous cell carcinoma through mitochondrial dysfunction and p70S6K signaling pathway. Int. J. Mol. Sci. 21, 1612 (2020). https://doi.org/10.3390/IJMS21051612
C. Wei, Q. Fu, Cell death mediated by nanotechnology via the cuproptosis pathway: a novel horizon for cancer therapy. View. 20230001 (2023). https://doi.org/10.1002/VIW.20230001
J. **e, Y. Yang, Y. Gao, J. He, Cuproptosis: mechanisms and links with cancers, Mol. Cancer 2023 221. 22 1–30 (2023). https://doi.org/10.1186/S12943-023-01732-Y
D. Wu, S. Wang, G. Yu, X. Chen, Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew. Chem. Int. Ed. Engl. 60, 8018–8034 (2021). https://doi.org/10.1002/ANIE.202010281
Q. Zeng, X. Ma, Y. Song, Q. Chen, Q. Jiao, L. Zhou, Targeting regulated cell death in tumor nanomedicines. Theranostics. 12, 817 (2022). https://doi.org/10.7150/THNO.67932
Q. Kong, Z. Zhang, Cancer-associated pyroptosis: a new license to kill tumor. Front. Immunol. 14, 1082165 (2023). https://doi.org/10.3389/FIMMU.2023.1082165/BIBTEX
Y. Wang, T. Liu, X. Li, H. Sheng, X. Ma, L. Hao, Ferroptosis-inducing nanomedicine for cancer therapy. Front. Pharmacol. 12 (2021). https://doi.org/10.3389/FPHAR.2021.735965
L. Luo, H. Wang, W. Tian, X. Li, Z. Zhu, R. Huang, H. Luo, Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics. 11, 9937 (2021). https://doi.org/10.7150/THNO.65480
C. Bae, H. Kim, Y.M. Kook, C. Lee, C. Kim, C. Yang, M.H. Park, Y. Piao, W.G. Koh, K. Lee, Induction of ferroptosis using functionalized iron-based nanoparticles for anti-cancer therapy. Mater. Today Bio. 17, 100457 (2022). https://doi.org/10.1016/J.MTBIO.2022.100457
Q. Liu, Y. Zhao, H. Zhou, C. Chen, Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regen. Biomater. 10 (2023). https://doi.org/10.1093/RB/RBAD004
M. Rahman, K. Alam, A. Hafeez, R. Ilyas, S. Beg, Metallic nanoparticles in drug delivery and cancer treatment, Nanoformulation Strateg. Cancer Treat., 107–119 (2021). https://doi.org/10.1016/B978-0-12-821095-6.00008-2
S. Zafar, D. Jain, F.J. Ahmad, Metallic nanoparticles in drug delivery: concepts, challenges, and current advancement, Multifunct. Nanocarriers., 121–148 (2022). https://doi.org/10.1016/B978-0-323-85041-4.00007-X
T.T. Dongsar, T.S. Dongsar, M.A.S. Abourehab, N. Gupta, P. Kesharwani, Emerging application of magnetic nanoparticles for breast cancer therapy. Eur. Polym. J. 187, 111898 (2023). https://doi.org/10.1016/J.EURPOLYMJ.2023.111898
R. Baghban, M. Afarid, J. Soleymani, M. Rahimi, Were magnetic materials useful in cancer therapy? Biomed. Pharmacother. 144, 112321 (2021). https://doi.org/10.1016/J.BIOPHA.2021.112321
S. Kulkarni, S. Kumar, S. Acharya, S. Kulkarni, S. Kumar, S. Acharya, Gold nanoparticles in cancer therapeutics and diagnostics. Cureus. 14 (2022). https://doi.org/10.7759/CUREUS.30096
S. Thambiraj, S. Shruthi, R. Vijayalakshmi, D. Ravi Shankaran, Evaluation of cytotoxic activity of docetaxel loaded gold nanoparticles for lung cancer drug delivery, Cancer Treat. Res. Commun. 21, 100157 (2019). https://doi.org/10.1016/J.CTARC.2019.100157
C. Hepokur, İ.A. Kariper, S. Mısır, E. Ay, S. Tunoğlu, M.S. Ersez, Ü. Zeybek, S.E. Kuruca, İ. Yaylım, Silver nanoparticle/capecitabine for breast cancer cell treatment. Toxicol. Vitr. 61, 104600 (2019). https://doi.org/10.1016/J.TIV.2019.104600
J. Nayak, K.S. Prajapati, S. Kumar, V.K. Vashistha, S.K. Sahoo, R. Kumar, Thiolated β-cyclodextrin modified iron oxide nanoparticles for effective targeted cancer therapy. Mater. Today Commun. 33, 104644 (2022). https://doi.org/10.1016/J.MTCOMM.2022.104644
V.J. Sawant, S.R. Bamane, PEG-beta-cyclodextrin functionalized zinc oxide nanoparticles show cell imaging with high drug payload and sustained pH responsive delivery of curcumin in to MCF-7 cells. J. Drug Deliv. Sci. Technol. 43, 397–408 (2018). https://doi.org/10.1016/J.JDDST.2017.11.010
J. Du, J. Sun, X. Liu, Q. Wu, W. Shen, Y. Gao, Y. Liu, C. Wu, Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma. Eur. J. Pharm. Sci. 180, 106338 (2023). https://doi.org/10.1016/J.EJPS.2022.106338
J. Song, L. Lin, Z. Yang, R. Zhu, Z. Zhou, Z.W. Li, F. Wang, J. Chen, H. Yang, X. Chen, Self-assembled responsive bilayered vesicles with adjustable oxidative stress for enhanced cancer imaging and therapy. J. Am. Chem. Soc. 141, 8158–8170 (2019). https://doi.org/10.1021/JACS.8B13902
H.S. Ali, B.M. El-Haj, S. Saifullah, M. Kawish, Gold nanoparticles in cancer diagnosis and therapy. Met. Nanoparticles Drug Deliv. Diagnostic Appl., 43–58 (2020). https://doi.org/10.1016/B978-0-12-816960-5.00004-5
J.B. Vines, J.H. Yoon, N.E. Ryu, D.J. Lim, H. Park, Gold nanoparticles for photothermal cancer therapy. Front. Chem. 7, 432792 (2019). https://doi.org/10.3389/FCHEM.2019.00167/BIBTEX
S. Medici, M. Peana, D. Coradduzza, M.A. Zoroddu, Gold nanoparticles and cancer: detection, diagnosis and therapy. Semin. Cancer Biol. 76, 27–37 (2021). https://doi.org/10.1016/J.SEMCANCER.2021.06.017
Z. Yang, D. Wang, C. Zhang, H. Liu, M. Hao, S. Kan, D. Liu, W. Liu, The applications of gold nanoparticles in the diagnosis and treatment of gastrointestinal cancer. Front. Oncol. 11, 819329 (2022). https://doi.org/10.3389/FONC.2021.819329/BIBTEX
E. Alchera, M. Monieri, M. Maturi, I. Locatelli, E. Locatelli, S. Tortorella, A. Sacchi, A. Corti, M. Nebuloni, R. Lucianò, F. Pederzoli, F. Montorsi, A. Salonia, S. Meyer, J. Jose, P. Giustetto, M.C. Franchini, F. Curnis, M. Alfano, Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics. 28, 100400 (2022). https://doi.org/10.1016/J.PACS.2022.100400
W. Gao, W. Wang, S. Yao, S. Wu, H. Zhang, J. Zhang, F. **g, H. Mao, Q. **, H. Cong, C. Jia, G. Zhang, J. Zhao, Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays. Anal. Chim. Acta. 958, 77–84 (2017). https://doi.org/10.1016/J.ACA.2016.12.016
H. Banu, D.K. Sethi, A. Edgar, A. Sheriff, N. Rayees, N. Renuka, S.M. Faheem, K. Premkumar, G. Vasanthakumar, Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines. J. Photochem. Photobiol. B Biol. 149, 116–128 (2015). https://doi.org/10.1016/J.JPHOTOBIOL.2015.05.008
M. Amirishoar, S. Noori, J. Mohammadnejad, M.R. Bazl, A. Narmani, Design and fabrication of folic acid-conjugated and gold-loaded poly (lactic-co-glycolic acid) biopolymers for suppression of breast cancer cell survival combining photothermal and photodynamic therapy. J. Drug Deliv. Sci. Technol. 83, 104266 (2023). https://doi.org/10.1016/J.JDDST.2023.104266
G.M. Vlăsceanu, Ş. Marin, R.E. Ţiplea, I.R. Bucur, M. Lemnaru, M.M. Marin, A.M. Grumezescu, E. Andronescu, Silver nanoparticles in cancer therapy, Nanobiomaterials Cancer Ther. Appl. Nanobiomaterials., 29–56 (2016). https://doi.org/10.1016/B978-0-323-42863-7.00002-5
P. Takáč, R. Michalková, M. Čižmáriková, Z. Bedlovičová, Ľ. Balážová, G. Takáčová, The role of silver nanoparticles in the diagnosis and treatment of cancer: are there any perspectives for the future? Life 13, 466 (2023). https://doi.org/10.3390/LIFE13020466
S. Gurunathan, M. Qasim, C. Park, H. Yoo, J.H. Kim, K. Hong, Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int. J. Mol. Sci 19, 2269 (2018). https://doi.org/10.3390/IJMS19082269
M.E. Abdel-Hameed, N.S. Farrag, H. Aglan, A.M. Amin, M.A. Mahdy, A new modality in targeted delivery of epirubicin for tumor theranosis based on PEGylated silver nanoparticles: design, radiolabeling and bioevaluation. Int. J. Pharm. 629, 122358 (2022). https://doi.org/10.1016/J.IJPHARM.2022.122358
M. Jeyaraj, G. Sathishkumar, G. Sivanandhan, D. MubarakAli, M. Rajesh, R. Arun, G. Kapildev, M. Manickavasagam, N. Thajuddin, K. Premkumar, A. Ganapathi, Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surfaces B Biointerfaces. 106, 86–92 (2013). https://doi.org/10.1016/J.COLSURFB.2013.01.027
S.M. Fayadh, A.H. Mohammed, Silver nanoparticles induced apoptosis in papillary and follicular thyroid carcinoma cells. Phys. Med. 14, 100056 (2022). https://doi.org/10.1016/J.PHMED.2022.100056
D.S. Parimi, Y. Gupta, S. Marpu, C.S. Bhatt, T.K. Bollu, A.K. Suresh, Nanomagnet-facilitated pharmaco-compatibility for cancer diagnostics: underlying risks and the emergence of ultrasmall nanomagnets. J. Pharm. Anal. 12, 365–379 (2022). https://doi.org/10.1016/J.JPHA.2021.11.002
Z. Bakhtiary, A.A. Saei, M.J. Hajipour, M. Raoufi, O. Vermesh, M. Mahmoudi, Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: possibilities and challenges, Nanomedicine Nanotechnology. Biol. Med. 12, 287–307 (2016). https://doi.org/10.1016/J.NANO.2015.10.019
I. Antal, M. Koneracka, M. Kubovcikova, V. Zavisova, I. Khmara, D. Lucanska, L. Jelenska, I. Vidlickova, M. Zatovicova, S. Pastorekova, N. Bugarova, M. Micusik, M. Omastova, P. Kopcansky, d,l-lysine functionalized Fe3O4 nanoparticles for detection of cancer cells. Colloids Surfaces B Biointerfaces. 163, 236–245 (2018). https://doi.org/10.1016/J.COLSURFB.2017.12.022
D. Zhi, T. Yang, J. Yang, S. Fu, S. Zhang, Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomater. 102, 13–34 (2020). https://doi.org/10.1016/J.ACTBIO.2019.11.027
Q. Mu, G. Lin, M. Jeon, H. Wang, F.C. Chang, R.A. Revia, J. Yu, M. Zhang, Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer. Mater. Today. 50, 149–169 (2021). https://doi.org/10.1016/J.MATTOD.2021.08.002
J.C.L. Chow, Magnetic nanoparticles as contrast agents in magnetic resonance imaging and radiosensitizers in radiotherapy. Fundam. Ind. Appl. Magn. Nanoparticles., 291–316 (2022). https://doi.org/10.1016/B978-0-12-822819-7.00002-8
S. Anjum, M. Hashim, S.A. Malik, M. Khan, J.M. Lorenzo, B.H. Abbasi, C. Hano, Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers (Basel). 13, 4570 (2021). https://doi.org/10.3390/CANCERS13184570
S. Ibraheem, A.A. Kadhim, K.A. Kadhim, I.A. Kadhim, M. Jabir, Zinc oxide nanoparticles as diagnostic tool for cancer cells. Int. J. Biomater. 2022 (2022). https://doi.org/10.1155/2022/2807644
T.A. Singh, J. Das, P.C. Sil, Zinc oxide nanoparticles: a comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks. Adv. Colloid Interface Sci. 286, 102317 (2020). https://doi.org/10.1016/J.CIS.2020.102317
Q. Tang, H. **a, W. Liang, X. Huo, X. Wei, Synthesis and characterization of zinc oxide nanoparticles from Morus nigra and its anticancer activity of AGS gastric cancer cells. J. Photochem. Photobiol. B Biol. 202, 111698 (2020). https://doi.org/10.1016/J.JPHOTOBIOL.2019.111698
R. Tanino, Y. Amano, X. Tong, R. Sun, Y. Tsubata, M. Harada, Y. Fujita, T. Isobe, Anticancer activity of ZnO nanoparticles against human small-cell lung cancer in an orthotopic mouse model. Mol. Cancer Ther. 19, 502–512 (2020). https://doi.org/10.1158/1535-7163.MCT-19-0018
J. Bonet-Aleta, J. Calzada-Funes, J.L. Hueso, Manganese oxide nano-platforms in cancer therapy: recent advances on the development of synergistic strategies targeting the tumor microenvironment. Appl. Mater. Today. 29, 101628 (2022). https://doi.org/10.1016/J.APMT.2022.101628
K.H. Bae, K. Lee, C. Kim, T.G. Park, Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials. 32, 176–184 (2011). https://doi.org/10.1016/J.BIOMATERIALS.2010.09.039
C. Li, Y. Zhang, M. Li, H. Zhang, Z. Zhu, Y. Xue, Fumaria officinalis-assisted synthesis of manganese nanoparticles as an anti-human gastric cancer agent. Arab. J. Chem. 14, 103309 (2021). https://doi.org/10.1016/J.ARABJC.2021.103309
M. Manikandan, N. Hasan, H.F. Wu, Platinum nanoparticles for the photothermal treatment of Neuro 2A cancer cells. Biomaterials. 34, 5833–5842 (2013). https://doi.org/10.1016/J.BIOMATERIALS.2013.03.077
S. Mukherjee, R. Kotcherlakota, S. Haque, D. Bhattacharya, J.M. Kumar, S. Chakravarty, C.R. Patra, Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma. Mater. Sci. Eng. C. 108, 110375 (2020). https://doi.org/10.1016/J.MSEC.2019.110375
G. Rajagopal, A. Nivetha, M. Sundar, T. Panneerselvam, S. Murugesan, P. Parasuraman, S. Kumar, S. Ilango, S. Kunjiappan, Mixed phytochemicals mediated synthesis of copper nanoparticles for anticancer and larvicidal applications. Heliyon. 7, e07360 (2021). https://doi.org/10.1016/J.HELIYON.2021.E07360
X. Kang, J. Wang, C.H. Huang, F.S. Wibowo, R. Amin, P. Chen, F. Li, Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein, Nanomedicine Nanotechnology. Biol. Med. 47, 102620 (2023). https://doi.org/10.1016/J.NANO.2022.102620
J. Deng, S. Xu, W. Hu, X. Xun, L. Zheng, M. Su, Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer. Biomaterials. 154, 24–33 (2018). https://doi.org/10.1016/J.BIOMATERIALS.2017.10.048
K. Brindhadevi, H.A.L. Garalleh, A. Alalawi, E. Al-Sarayreh, A. Pugazhendhi, Carbon nanomaterials: types, synthesis strategies and their application as drug delivery system for cancer therapy. Biochem. Eng. J. 192, 108828 (2023). https://doi.org/10.1016/J.BEJ.2023.108828
J.R. Siqueira, O.N. Oliveira, Carbon-based nanomaterials, Nanostructures. (2017) 233–249. https://doi.org/10.1016/B978-0-323-49782-4.00009-7.
N.J. Singhai, R. Maheshwari, N.K. Jain, S. Ramteke, Chondroitin sulphate and α-tocopheryl succinate tethered multiwalled carbon nanotubes for dual-action therapy of triple-negative breast cancer. J. Drug Deliv. Sci. Technol. 60, 102080 (2020). https://doi.org/10.1016/J.JDDST.2020.102080
Z. Ji, G. Lin, Q. Lu, L. Meng, X. Shen, L. Dong, C. Fu, X. Zhang, Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J. Colloid Interface Sci. 365, 143–149 (2012). https://doi.org/10.1016/J.JCIS.2011.09.013
N. Ghanbari, Z. Salehi, A.A. Khodadadi, M.A. Shokrgozar, A.A. Saboury, F. Farzaneh, Tryptophan-functionalized graphene quantum dots with enhanced curcumin loading capacity and pH-sensitive release. J. Drug Deliv. Sci. Technol. 61, 102137 (2021). https://doi.org/10.1016/J.JDDST.2020.102137
H. Yao, S. Zhang, X. Guo, Y. Li, J. Ren, H. Zhou, B. Du, J. Zhou, A traceable nanoplatform for enhanced chemo-photodynamic therapy by reducing oxygen consumption, Nanomedicine Nanotechnology. Biol. Med. 20, 101978 (2019). https://doi.org/10.1016/J.NANO.2019.03.001
K. Vinothini, N.K. Rajendran, A. Ramu, N. Elumalai, M. Rajan, Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier. Biomed. Pharmacother. 110, 906–917 (2019). https://doi.org/10.1016/J.BIOPHA.2018.12.008
J. Shi, H. Zhang, L. Wang, L. Li, H. Wang, Z. Wang, Z. Li, C. Chen, L. Hou, C. Zhang, Z. Zhang, PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials. 34, 251–261 (2013). https://doi.org/10.1016/J.BIOMATERIALS.2012.09.039
R. Singh, R. Deshmukh, Carbon nanotube as an emerging theranostic tool for oncology. J. Drug Deliv. Sci. Technol. 74, 103586 (2022). https://doi.org/10.1016/J.JDDST.2022.103586
N. Yadav, M. Tyagi, S. Wadhwa, A. Mathur, J. Narang, Few biomedical applications of carbon nanotubes. Methods Enzymol. 630, 347–363 (2020). https://doi.org/10.1016/BS.MIE.2019.11.005
S.r. Ji, C. Liu, B. Zhang, F. Yang, J. Xu, J. Long, C. **, D.l. Fu, Q.x. Ni, X.j. Yu, Carbon nanotubes in cancer diagnosis and therapy. Biochim. Biophys. Acta - Rev. Cancer. 1806, 29–35 (2010). https://doi.org/10.1016/J.BBCAN.2010.02.004
A. Yaghoubi, A. Ramazani, Anticancer DOX delivery system based on CNTs: functionalization, targeting and novel technologies. J. Control. Release. 327, 198–224 (2020). https://doi.org/10.1016/J.JCONREL.2020.08.001
J. Ma, G. Wang, X. Ding, F. Wang, C. Zhu, Y. Rong, Carbon-based nanomaterials as drug delivery agents for colorectal cancer: clinical preface to colorectal cancer citing their markers and existing theranostic approaches. ACS Omega. (2023). https://doi.org/10.1021/ACSOMEGA.2C06242/ASSET/IMAGES/LARGE/AO2C06242_0002.JPEG
P. Gulati, P. Kaur, M.V. Rajam, T. Srivastava, P. Mishra, S.S. Islam, Single-wall carbon nanotube based electrochemical immunoassay for leukemia detection. Anal. Biochem. 557, 111–119 (2018). https://doi.org/10.1016/J.AB.2018.07.020
J.M. González-Domínguez, L. Grasa, J. Frontiñán-Rubio, E. Abás, A. Domínguez-Alfaro, J.E. Mesonero, A. Criado, A. Ansón-Casaos, Intrinsic and selective activity of functionalized carbon nanotube/nanocellulose platforms against colon cancer cells. Colloids Surfaces B Biointerfaces. 212, 112363 (2022). https://doi.org/10.1016/J.COLSURFB.2022.112363
H.J. Yao, L. Sun, Y. Liu, S. Jiang, Y. Pu, J. Li, Y. Zhang, Monodistearoylphosphatidylethanolamine-hyaluronic acid functionalization of single-walled carbon nanotubes for targeting intracellular drug delivery to overcome multidrug resistance of cancer cells. Carbon N. Y. 96, 362–376 (2016). https://doi.org/10.1016/J.CARBON.2015.09.037
W. **, R. Zhang, C. Dong, T. Jiang, Y. Tian, Q. Yang, W. Yi, J. Hou, A simple MWCNTs@paper biosensor for CA19-9 detection and its long-term preservation by vacuum freeze drying. Int. J. Biol. Macromol. 144, 995–1003 (2020). https://doi.org/10.1016/J.IJBIOMAC.2019.09.176
M.R.M. Radzi, N.A. Johari, W.F.A.W.M. Zawawi, N.A. Zawawi, N.A. Latiff, N.A.N.N. Malek, A.A. Wahab, M.I. Salim, K. Jemon, In vivo evaluation of oxidized multiwalled-carbon nanotubes-mediated hyperthermia treatment for breast cancer, Biomater. Adv. 134, 112586 (2022). https://doi.org/10.1016/J.MSEC.2021.112586
N.J. Singhai, R. Maheshwari, S. Ramteke, CD44 receptor targeted ‘smart’ multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer. Colloid Interface Sci. Commun. 35, 100235 (2020). https://doi.org/10.1016/J.COLCOM.2020.100235
A. Lohani, S. Durgapal, P. Morganti, Quantum dots: an emerging implication of nanotechnology in cancer diagnosis and therapy. Quantum Mater. Devices, Appl., 243–262 (2023). https://doi.org/10.1016/B978-0-12-820566-2.00008-9
J.O. Fernandes, C.A.R. Bernardino, B.F. Braz, C.F. Mahler, R.E. Santelli, F.H. Cincotto, (Bio)sensing materials: quantum dots, Encycl. Sensors Biosens., 389–400 (2023). https://doi.org/10.1016/B978-0-12-822548-6.00017-0
L.A. Bentolila, Photoluminescent quantum dots in imaging, diagnostics and therapy. Appl. Nanosci. Photomed., 77–104 (2015). https://doi.org/10.1533/9781908818782.77
D. Onoshima, H. Yukawa, Y. Baba, Multifunctional quantum dots-based cancer diagnostics and stem cell therapeutics for regenerative medicine. Adv. Drug Deliv. Rev. 95, 2–14 (2015). https://doi.org/10.1016/J.ADDR.2015.08.004
F. Yazdian, Aptamer-functionalized quantum dots for targeted cancer therapy. Aptamers Eng. Nanocarriers Cancer Ther., 295–315 (2023). https://doi.org/10.1016/B978-0-323-85881-6.00012-9
H.R.A.K. Al-Hetty, A.T. Jalil, J.H.Z. Al-Tamimi, H.G. Shakier, M. Kandeel, M.M. Saleh, M. Naderifar, Engineering and surface modification of carbon quantum dots for cancer bioimaging. Inorg. Chem. Commun. 149, 110433 (2023). https://doi.org/10.1016/J.INOCHE.2023.110433
D. Radenkovic, H. Kobayashi, E. Remsey-Semmelweis, A.M. Seifalian, Quantum dot nanoparticle for optimization of breast cancer diagnostics and therapy in a clinical setting, Nanomedicine Nanotechnology. Biol. Med. 12, 1581–1592 (2016). https://doi.org/10.1016/J.NANO.2016.02.014
G. Bharathi, F. Lin, L. Liu, T.Y. Ohulchanskyy, R. Hu, J. Qu, An all-graphene quantum dot Förster resonance energy transfer (FRET) probe for ratiometric detection of HE4 ovarian cancer biomarker. Colloids Surfaces B Biointerfaces. 198, 111458 (2021). https://doi.org/10.1016/J.COLSURFB.2020.111458
N. Dhas, M. Pastagia, A. Sharma, A. Khera, R. Kudarha, S. Kulkarni, S. Soman, S. Mutalik, R.P. Barnwal, G. Singh, M. Patel, Organic quantum dots: an ultrasmall nanoplatform for cancer theranostics. J. Control. Release. 348, 798–824 (2022). https://doi.org/10.1016/J.JCONREL.2022.06.033
A. Karagianni, N.G. Tsierkezos, M. Prato, M. Terrones, K.V. Kordatos, Application of carbon-based quantum dots in photodynamic therapy. Carbon N. Y. 203, 273–310 (2023). https://doi.org/10.1016/J.CARBON.2022.11.026
E. Nosheen, A. Shah, F.J. Iftikhar, S. Aftab, N.K. Bakirhan, S.A. Ozkan, Optical nanosensors for pharmaceutical detection, New Dev. Nanosensors Pharm. Anal., 119–140 (2019). https://doi.org/10.1016/B978-0-12-816144-9.00004-3
D. Iannazzo, A. Pistone, M. Salamò, S. Galvagno, R. Romeo, S.V. Giofré, C. Branca, G. Visalli, A. Di Pietro, Graphene quantum dots for cancer targeted drug delivery. Int. J. Pharm. 518, 185–192 (2017). https://doi.org/10.1016/J.IJPHARM.2016.12.060
M. Mahani, M. Pourrahmani-Sarbanani, M. Yoosefian, F. Divsar, S.M. Mousavi, A. Nomani, Doxorubicin delivery to breast cancer cells with transferrin-targeted carbon quantum dots: an in vitro and in silico study. J. Drug Deliv. Sci. Technol. 62, 102342 (2021). https://doi.org/10.1016/J.JDDST.2021.102342
S. Barua, X. Geng, B. Chen, Graphene-based nanomaterials for healthcare applications, Photonanotechnology Ther. Imaging., 45–81 (2020). https://doi.org/10.1016/B978-0-12-817840-9.00003-5
J. Lin, Y. Huang, P. Huang, Graphene-based nanomaterials in bioimaging. Biomed. Appl. Funct. Nanomater. Concepts, Dev. Clin. Transl., 247–287 (2018). https://doi.org/10.1016/B978-0-323-50878-0.00009-4
F. Alemi, R. Zarezadeh, A.R. Sadigh, H. Hamishehkar, M. Rahimi, M. Majidinia, Z. Asemi, A. Ebrahimi-Kalan, B. Yousefi, N. Rashtchizadeh, Graphene oxide and reduced graphene oxide: efficient cargo platforms for cancer theranostics. J. Drug Deliv. Sci. Technol. 60, 101974 (2020). https://doi.org/10.1016/J.JDDST.2020.101974
C. Hu, L. Zhang, Z. Yang, Z. Song, Q. Zhang, Y. He, Graphene oxide-based qRT-PCR assay enables the sensitive and specific detection of miRNAs for the screening of ovarian cancer. Anal. Chim. Acta. 1174, 338715 (2021). https://doi.org/10.1016/J.ACA.2021.338715
M.K. Filippidou, C.M. Loukas, G. Kaprou, E. Tegou, P. Petrou, S. Kakabakos, A. Tserepi, S. Chatzandroulis, Detection of BRCA1 gene on partially reduced graphene oxide biosensors. Microelectron. Eng. 216, 111093 (2019). https://doi.org/10.1016/J.MEE.2019.111093
N. Ma, J. Liu, W. He, Z. Li, Y. Luan, Y. Song, S. Garg, Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J. Colloid Interface Sci. 490, 598–607 (2017). https://doi.org/10.1016/J.JCIS.2016.11.097
L. Zhou, L. Zhou, S. Wei, X. Ge, J. Zhou, H. Jiang, F. Li, J. Shen, Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system. J. Photochem. Photobiol. B Biol. 135, 7–16 (2014). https://doi.org/10.1016/J.JPHOTOBIOL.2014.04.010
X. Wei, P. Li, H. Zhou, X. Hu, D. Liu, J. Wu, Y. Wang, Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy. J. Photochem. Photobiol. B Biol. 216, 112125 (2021). https://doi.org/10.1016/J.JPHOTOBIOL.2021.112125
S. Goodarzi, T. Da Ros, J. Conde, F. Sefat, M. Mozafari, Fullerene: biomedical engineers get to revisit an old friend. Mater. Today. 20, 460–480 (2017). https://doi.org/10.1016/J.MATTOD.2017.03.017
A. Grebinyk, S. Prylutska, S. Grebinyk, Y. Prylutskyy, U. Ritter, O. Matyshevska, T. Dandekar, M. Frohme, Toward photodynamic cancer chemotherapy with C60-doxorubicin nanocomplexes. Nanomater. Photodyn. Ther., 489–522 (2023). https://doi.org/10.1016/B978-0-323-85595-2.00005-0
A.Y. Rybkin, A.V. Kozlov, A.Y. Belik, A.I. Kotelnikov, Fullerenes and fullerene–dye structures in photodynamic therapy, Nanomater. Photodyn. Ther., 349–399 (2023). https://doi.org/10.1016/B978-0-323-85595-2.00012-8
H.J. Huang, M. Chetyrkina, C.W. Wong, O.A. Kraevaya, A.V. Zhilenkov, I.I. Voronov, P.H. Wang, P.A. Troshin, S.h. Hsu, Identification of potential descriptors of water-soluble fullerene derivatives responsible for antitumor effects on lung cancer cells via QSAR analysis. Comput. Struct. Biotechnol. J. 19, 812–825 (2021). https://doi.org/10.1016/J.CSBJ.2021.01.012
J.R. Xu, Y. **e, J.W. Li, R. Liu, M. Chen, Y.X. Ren, Q. Luo, J.L. Duan, C.J. Bao, Y.X. Liu, P.S. Li, W.L. Lu, Development of fullerene nanospherical miRNA and application in overcoming resistant breast cancer. Mater. Today Chem. 26, 101019 (2022). https://doi.org/10.1016/J.MTCHEM.2022.101019
J. Shi, Y. Liu, L. Wang, J. Gao, J. Zhang, X. Yu, R. Ma, R. Liu, Z. Zhang, A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Acta Biomater 10, 1280–1291 (2014). https://doi.org/10.1016/J.ACTBIO.2013.10.037
S. Beyaz, A. Aslan, O. Gok, H. Uslu, C.A. Agca, I.H. Ozercan, In vivo, in vitro and in silico anticancer investigation of fullerene C60 on DMBA induced breast cancer in rats. Life Sci. 291, 120281 (2022). https://doi.org/10.1016/J.LFS.2021.120281
Y. Peng, D. Yang, W. Lu, X. Hu, H. Hong, T. Cai, Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance. Acta Biomater 61, 193–203 (2017). https://doi.org/10.1016/J.ACTBIO.2017.08.011
G.S. Simate, Synthesis of advanced carbon-based nanocomposites for biomedical application. Sustain. Nanotechnol. Environ. Remediat., 571–611 (2022). https://doi.org/10.1016/B978-0-12-824547-7.00019-9
G. Chen, Y. Qian, H. Zhang, A. Ullah, X. He, Z. Zhou, H. Fenniri, J. Shen, Advances in cancer theranostics using organic-inorganic hybrid nanotechnology. Appl. Mater. Today. 23, 101003 (2021). https://doi.org/10.1016/J.APMT.2021.101003
G. Dutta, S. Manickam, A. Sugumaran, Stimuli-responsive hybrid metal nanocomposite – a promising technology for effective anticancer therapy. Int. J. Pharm. 624, 121966 (2022). https://doi.org/10.1016/J.IJPHARM.2022.121966
A.O. Oladipo, S.I.I. Iku, M. Ntwasa, T.T.I. Nkambule, B.B. Mamba, T.A.M. Msagati, Doxorubicin conjugated hydrophilic AuPt bimetallic nanoparticles fabricated from Phragmites australis: characterization and cytotoxic activity against human cancer cells. J. Drug Deliv. Sci. Technol. 57, 101749 (2020). https://doi.org/10.1016/J.JDDST.2020.101749
E. Soratijahromi, S. Mohammadi, R. Dehdari Vais, N. Azarpira, N. Sattarahmady, Photothermal/sonodynamic therapy of melanoma tumor by a gold/manganese dioxide nanocomposite: in vitro and in vivo studies. Photodiagnosis Photodyn. Ther. 31, 101846 (2020). https://doi.org/10.1016/J.PDPDT.2020.101846
P. Das, S.V. Mudigunda, G. Darabdhara, P.K. Boruah, S. Ghar, A.K. Rengan, M.R. Das, Biocompatible functionalized AuPd bimetallic nanoparticles decorated on reduced graphene oxide sheets for photothermal therapy of targeted cancer cells. J. Photochem. Photobiol. B Biol. 212, 112028 (2020). https://doi.org/10.1016/J.JPHOTOBIOL.2020.112028
J. Shi, L. Wang, J. Gao, Y. Liu, J. Zhang, R. Ma, R. Liu, Z. Zhang, A fullerene-based multi-functional nanoplatform for cancer theranostic applications. Biomaterials. 35, 5771–5784 (2014). https://doi.org/10.1016/J.BIOMATERIALS.2014.03.071
M.K. Kumawat, M. Thakur, R. Bahadur, T. Kaku, R.S. Prabhuraj, A. Ninawe, R. Srivastava, Preparation of graphene oxide-graphene quantum dots hybrid and its application in cancer theranostics. Mater. Sci. Eng. C. 103, 109774 (2019). https://doi.org/10.1016/J.MSEC.2019.109774
H. Ramsurn, R.B. Gupta, Hydrogenation by nanoparticle catalysts, New Futur. Dev. Catal. Catal. by Nanoparticles., 347–374 (2013). https://doi.org/10.1016/B978-0-444-53874-1.00016-0
G. Sharma, A. Kumar, S. Sharma, M. Naushad, R. Prakash Dwivedi, Z.A. ALOthman, G.T. Mola, Novel development of nanoparticles to bimetallic nanoparticles and their composites: a review. J. King Saud Univ. - Sci. 31, 257–269 (2019). https://doi.org/10.1016/J.JKSUS.2017.06.012
A. Zaleska-Medynska, M. Marchelek, M. Diak, E. Grabowska, Noble metal-based bimetallic nanoparticles: the effect of the structure on the optical, catalytic and photocatalytic properties. Adv. Colloid Interface Sci. 229, 80–107 (2016). https://doi.org/10.1016/J.CIS.2015.12.008
V. Amendola, A. Guadagnini, S. Agnoli, D. Badocco, P. Pastore, G. Fracasso, M. Gerosa, F. Vurro, A. Busato, P. Marzola, Polymer-coated silver-iron nanoparticles as efficient and biodegradable MRI contrast agents. J. Colloid Interface Sci. 596, 332–341 (2021). https://doi.org/10.1016/J.JCIS.2021.03.096
A. Naghilou, O. Bomati-Miguel, A. Subotic, R. Lahoz, M. Kitzler-Zeiler, C. Radtke, M.A. Rodríguez, W. Kautek, Femtosecond laser generation of bimetallic oxide nanoparticles with potential X-ray absorbing and magnetic functionalities for medical imaging applications. Ceram. Int. 47, 29363–29370 (2021). https://doi.org/10.1016/J.CERAMINT.2021.07.103
F. He, H. Ji, L. Feng, Z. Wang, Q. Sun, C. Zhong, D. Yang, S. Gai, P. Yang, J. Lin, Construction of thiol-capped ultrasmall Au–Bi bimetallic nanoparticles for X-ray CT imaging and enhanced antitumor therapy efficiency. Biomaterials. 264, 120453 (2021). https://doi.org/10.1016/J.BIOMATERIALS.2020.120453
K.A. Elsayed, M. Alomari, Q.A. Drmosh, M. Alheshibri, A. Al Baroot, T.S. Kayed, A.A. Manda, A.L. Al-Alotaibi, Fabrication of ZnO-Ag bimetallic nanoparticles by laser ablation for anticancer activity. Alexandria Eng. J. 61, 1449–1457 (2022). https://doi.org/10.1016/J.AEJ.2021.06.051
Y. Song, Z. Qu, J. Li, L. Shi, W. Zhao, H. Wang, T. Sun, T. Jia, Y. Sun, Fabrication of the biomimetic DOX/Au@Pt nanoparticles hybrid nanostructures for the combinational chemo/photothermal cancer therapy. J. Alloys Compd. 881, 160592 (2021). https://doi.org/10.1016/J.JALLCOM.2021.160592
P. Shende, P. Shah, Carbohydrate-based magnetic nanocomposites for effective cancer treatment. Int. J. Biol. Macromol. 175, 281–293 (2021). https://doi.org/10.1016/J.IJBIOMAC.2021.02.044
P. Bhatia, S.S. Verma, M.M. Sinha, Tunable plasmonic properties of elongated bimetallic alloys nanoparticles towards deep UV-NIR absorbance and sensing. J. Quant. Spectrosc. Radiat. Transf. 241, 106751 (2020). https://doi.org/10.1016/J.JQSRT.2019.106751
H. Du, O.U. Akakuru, C. Yao, F. Yang, A. Wu, Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy. Transl. Oncol. 15, 101264 (2022). https://doi.org/10.1016/J.TRANON.2021.101264
C. de la Encarnación, D. Jimenez de Aberasturi, L.M. Liz-Marzán, Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia. Adv. Drug Deliv. Rev. 189, 114484 (2022). https://doi.org/10.1016/J.ADDR.2022.114484
M.P. Desai, A.C. Paiva-Santos, M.S. Nimbalkar, K.D. Sonawane, P.S. Patil, K.D. Pawar, Iron tolerant Bacillus badius mediated bimetallic magnetic iron oxide and gold nanoparticles as doxorubicin carrier and for hyperthermia treatment. J. Drug Deliv. Sci. Technol. 81, 104214 (2023). https://doi.org/10.1016/J.JDDST.2023.104214
P. Pandit, S. Bhagat, P. Rananaware, Z. Mohanta, M. Kumar, V. Tiwari, S. Singh, V.P. Brahmkhatri, Iron oxide nanoparticle encapsulated; folic acid tethered dual metal organic framework-based nanocomposite for MRI and selective targeting of folate receptor expressing breast cancer cells. Microporous Mesoporous Mater. 340, 112008 (2022). https://doi.org/10.1016/J.MICROMESO.2022.112008
M. Attia, R.D. Glickman, G. Romero, B. Chen, A.J. Brenner, J.Y. Ye, Optimized metal-organic-framework based magnetic nanocomposites for efficient drug delivery and controlled release. J. Drug Deliv. Sci. Technol. 76, 103770 (2022). https://doi.org/10.1016/J.JDDST.2022.103770
S. Naser Mohammed, A. Mishaal Mohammed, K.F. Al-Rawi, Novel combination of multi-walled carbon nanotubes and gold nanocomposite for photothermal therapy in human breast cancer model. Steroids. 186, 109091 (2022). https://doi.org/10.1016/J.STEROIDS.2022.109091
M.F. Naief, Y.H. Khalaf, A.M. Mohammed, Novel photothermal therapy using multi-walled carbon nanotubes and platinum nanocomposite for human prostate cancer PC3 cell line. J. Organomet. Chem. 975, 122422 (2022). https://doi.org/10.1016/J.JORGANCHEM.2022.122422
N. Dhas, K. Parekh, A. Pandey, R. Kudarha, S. Mutalik, T. Mehta, Two dimensional carbon based nanocomposites as multimodal therapeutic and diagnostic platform: a biomedical and toxicological perspective. J. Control. Release. 308, 130–161 (2019). https://doi.org/10.1016/J.JCONREL.2019.07.016
R. Henglei, G. Chunli, L. Min, Z. Liang, Bimetallic Au–Pd nanoparticles/RGO as theranostic nanoplatform for photothermal therapy of throat cancer - an in vitro approach. J. Radiat. Res. Appl. Sci. 15, 100473 (2022). https://doi.org/10.1016/J.JRRAS.2022.100473
N. Tejwan, A.K. Saini, A. Sharma, T.A. Singh, N. Kumar, J. Das, Metal-doped and hybrid carbon dots: a comprehensive review on their synthesis and biomedical applications. J. Control. Release. 330, 132–150 (2021). https://doi.org/10.1016/J.JCONREL.2020.12.023
S. Hassani, N. Gharehaghaji, B. Divband, Chitosan-coated iron oxide/graphene quantum dots as a potential multifunctional nanohybrid for bimodal magnetic resonance/fluorescence imaging and 5-fluorouracil delivery. Mater. Today Commun. 31, 103589 (2022). https://doi.org/10.1016/J.MTCOMM.2022.103589
R. Ali, M.H. Aziz, S. Gao, M.I. Khan, F. Li, T. Batool, F. Shaheen, B. Qiu, Graphene oxide/zinc ferrite nanocomposite loaded with doxorubicin as a potential theranostic mediu in cancer therapy and magnetic resonance imaging. Ceram. Int. 48, 10741–10750 (2022). https://doi.org/10.1016/J.CERAMINT.2021.12.290
M. Gorgizadeh, N. Behzadpour, F. Salehi, F. Daneshvar, R.D. Vais, R. Nazari-Vanani, N. Azarpira, M. Lotfi, N. Sattarahmady, A MnFe2O4/C nanocomposite as a novel theranostic agent in MRI, sonodynamic therapy and photothermal therapy of a melanoma cancer model. J. Alloys Compd. 816, 152597 (2020). https://doi.org/10.1016/J.JALLCOM.2019.152597
M.İ. Özsoy, S. Türk, F. Fındık, M. Özacar, Carbon–carbon nanocomposites for brake systems and exhaust nozzles. Nanotechnol. Automot. Ind., 131–154 (2022). https://doi.org/10.1016/B978-0-323-90524-4.00007-4
M. Zhang, W. Wang, F. Wu, P. Yuan, C. Chi, N. Zhou, Magnetic and fluorescent carbon nanotubes for dual modal imaging and photothermal and chemo-therapy of cancer cells in living mice. Carbon N. Y. 123, 70–83 (2017). https://doi.org/10.1016/J.CARBON.2017.07.032
J.-J. Xu, W.-C. Zhang, Y.-W. Guo, X.-Y. Chen, Y.-N. Zhang, Metal nanoparticles as a promising technology in targeted cancer treatment. (2022). https://doi.org/10.1080/10717544.2022.2039804
J. Verma, C. Warsame, R.K. Seenivasagam, N.K. Katiyar, E. Aleem, S. Goel, Nanoparticle-mediated cancer cell therapy: basic science to clinical applications. Cancer Metastasis Rev. 2023(1), 1–27 (2023). https://doi.org/10.1007/S10555-023-10086-2
E.K. Schneider-Futschik, F. Reyes-Ortega, Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders. Pharmaceutics. 13 (2021). https://doi.org/10.3390/PHARMACEUTICS13081157
Z. Chen, A. Zhang, X. Wang, J. Zhu, Y. Fan, H. Yu, Z. Yang, The advances of carbon nanotubes in cancer diagnostics and therapeutics. J. Nanomater. 2017 (2017). https://doi.org/10.1155/2017/3418932
L. Tang, J. Li, T. Pan, Y. Yin, Y. Mei, Q. **ao, R. Wang, Z. Yan, W. Wang, Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives. Theranostics. 12, 2290–2321 (2022). https://doi.org/10.7150/THNO.69628
S.N. Bhatia, X. Chen, M.A. Dobrovolskaia, T. Lammers, Cancer nanomedicine. Nat. Rev. Cancer. 22, 550–556 (2022). https://doi.org/10.1038/S41568-022-00496-9
C. Roma-Rodrigues, I. Pombo, L. Raposo, P. Pedrosa, A.R. Fernandes, P.V. Baptista, Nanotheranostics targeting the tumor microenvironment. Front. Bioeng. Biotechnol. 7, 197 (2019). https://doi.org/10.3389/FBIOE.2019.00197
Acknowledgements
The authors are highly thankful to Department of Biotechnology Engineering, University Institute of Engineering & Technology, Maharshi Dayanand University for providing necessary facilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Loura, N., Singh, M. & Dhull, V. Elite nanomaterials in cancer detection and therapy. emergent mater. 6, 1415–1440 (2023). https://doi.org/10.1007/s42247-023-00539-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42247-023-00539-3